OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions
Joshua D. Brown, Kevin J. Rivera Rivera, Leilanie Y. Crespo Hernandez, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 29
Joshua D. Brown, Kevin J. Rivera Rivera, Leilanie Y. Crespo Hernandez, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 19
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 19
Cannabis for Chronic Pain: Mechanistic Insights and Therapeutic Challenges
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Carla Matos, Ana Teresa Pereira, Maria João Dias, et al.
Stresses (2025) Vol. 5, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review
Lauren Rice, Lisa Cannon, Navin Dadlani, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 505-526
Open Access | Times Cited: 14
Lauren Rice, Lisa Cannon, Navin Dadlani, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 2, pp. 505-526
Open Access | Times Cited: 14
The Association Between Past 12-Month Synthetic Cannabinoid Polysubstance Use and Cannabis Use Disorder in a Nationally Representative US Sample
Weisiyu Qin, Dong‐Chul Seo, Shin Hyung Lee, et al.
International Journal of Mental Health and Addiction (2025)
Closed Access
Weisiyu Qin, Dong‐Chul Seo, Shin Hyung Lee, et al.
International Journal of Mental Health and Addiction (2025)
Closed Access
The Resurgence of Synthetic Cannabinoid Receptor Agonists as Adulterants in the Era of Cannabis Legalization: Lessons from Prior Epidemics and Clinical Implications
Aaron P. Jones, Ali S. Taha, Grover P. Miller
Neuroscience & Biobehavioral Reviews (2025), pp. 106043-106043
Closed Access
Aaron P. Jones, Ali S. Taha, Grover P. Miller
Neuroscience & Biobehavioral Reviews (2025), pp. 106043-106043
Closed Access
New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 11
Chinaza Godswill Awuchi, Patrick Maduabuchi Aja, Nancy Bonareri Mitaki, et al.
Journal of Chemistry (2023) Vol. 2023, pp. 1-36
Open Access | Times Cited: 11
Comprehensive Safety Assessment of Diverse Cannabinoids: A Scientific Inquiry
Maite L. Docampo Palacios, Giovanni A. Ramirez, Tesfay Tesfatsion, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3
Maite L. Docampo Palacios, Giovanni A. Ramirez, Tesfay Tesfatsion, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3
Endocannabinoid-Binding Receptors as Drug Targets
María Gómez‐Cañas, Carmen Rodríguez‐Cueto, Valentina Satta, et al.
Methods in molecular biology (2022), pp. 67-94
Closed Access | Times Cited: 14
María Gómez‐Cañas, Carmen Rodríguez‐Cueto, Valentina Satta, et al.
Methods in molecular biology (2022), pp. 67-94
Closed Access | Times Cited: 14
Prevalence and Frequency of Cannabis Use Among Adults Ages 50–80 in the United States
Anne C. Fernandez, Lara N. Coughlin, Erica Solway, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 1, pp. 59-64
Closed Access | Times Cited: 8
Anne C. Fernandez, Lara N. Coughlin, Erica Solway, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 1, pp. 59-64
Closed Access | Times Cited: 8
The association between hematological markers of inflammation and chronic cannabis use: a systematic review and meta-analysis of observational studies
Reza Moshfeghinia, Amirhossein Najibi, Mehrnaz Moradi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Reza Moshfeghinia, Amirhossein Najibi, Mehrnaz Moradi, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 12
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 12
Application of gas chromatography in the analysis of phytocannabinoids: An update (2020–2023)
Lutfun Nahar, Georgiana‐Luminita Gavril, Satyajit D. Sarker
Phytochemical Analysis (2023) Vol. 34, Iss. 8, pp. 903-924
Closed Access | Times Cited: 6
Lutfun Nahar, Georgiana‐Luminita Gavril, Satyajit D. Sarker
Phytochemical Analysis (2023) Vol. 34, Iss. 8, pp. 903-924
Closed Access | Times Cited: 6
Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress
Ilaria Capolupo, Maria Rosaria Miranda, Simona Musella, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1284-1284
Open Access | Times Cited: 1
Ilaria Capolupo, Maria Rosaria Miranda, Simona Musella, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1284-1284
Open Access | Times Cited: 1
The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury
Andrea Duranti, Gorane Beldarrain, Antonia Álvarez, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 7
Andrea Duranti, Gorane Beldarrain, Antonia Álvarez, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 7
Sensitive detection of synthetic cannabinoids in human blood using magnetic polydopamine molecularly imprinted polymer nanocomposites
Jiajia Li, Yong Wang, Anran Liu, et al.
The Analyst (2023) Vol. 148, Iss. 19, pp. 4850-4856
Closed Access | Times Cited: 3
Jiajia Li, Yong Wang, Anran Liu, et al.
The Analyst (2023) Vol. 148, Iss. 19, pp. 4850-4856
Closed Access | Times Cited: 3
A comprehensive review on detection of cannabinoids using hyphenated techniques
Srinidhi Krishnamurthy, Rashmi Dilip Kadu
Chemical Papers (2023) Vol. 77, Iss. 7, pp. 3501-3520
Closed Access | Times Cited: 2
Srinidhi Krishnamurthy, Rashmi Dilip Kadu
Chemical Papers (2023) Vol. 77, Iss. 7, pp. 3501-3520
Closed Access | Times Cited: 2
Clinical Considerations for Cannabis Use and Cardiovascular Health
Ruba Sajdeya, Sebastian Jugl, Robert L. Cook, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 120-127
Open Access | Times Cited: 3
Ruba Sajdeya, Sebastian Jugl, Robert L. Cook, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 120-127
Open Access | Times Cited: 3
The Impact of Hemp Derived Cannabinoid Potency from Consumer Product Goods on in vitro Lung and Liver Cells
Giovanni A. Ramirez, Maite L. Docampo Palacios, Tesfay Tesfatsion, et al.
Natural Product Communications (2024) Vol. 19, Iss. 11
Open Access
Giovanni A. Ramirez, Maite L. Docampo Palacios, Tesfay Tesfatsion, et al.
Natural Product Communications (2024) Vol. 19, Iss. 11
Open Access
The State of Synthetic Cannabinoid Medications for the Treatment of Pain
Anca Maglaviceanu, Miki Peer, Jason S. Rockel, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 597-612
Closed Access
Anca Maglaviceanu, Miki Peer, Jason S. Rockel, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 597-612
Closed Access
The Elusive Truth of Cannabinoids for Rheumatic Pain
Hance Clarke, Sarah Miles, Miki Peer, et al.
Current Rheumatology Reports (2024) Vol. 26, Iss. 11, pp. 392-402
Closed Access
Hance Clarke, Sarah Miles, Miki Peer, et al.
Current Rheumatology Reports (2024) Vol. 26, Iss. 11, pp. 392-402
Closed Access
Advances in urinary biomarker research of synthetic cannabinoids
Ziteng Wang, Eric Yu Quan Leow, Hooi Yan Moy, et al.
Advances in clinical chemistry (2023), pp. 1-32
Closed Access | Times Cited: 1
Ziteng Wang, Eric Yu Quan Leow, Hooi Yan Moy, et al.
Advances in clinical chemistry (2023), pp. 1-32
Closed Access | Times Cited: 1
Use of Selective Alternative Therapies for Treatment of OCD
Iman Khan, Taimoor Asif Jaura, Alaa Tukruna, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 721-732
Open Access | Times Cited: 1
Iman Khan, Taimoor Asif Jaura, Alaa Tukruna, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 721-732
Open Access | Times Cited: 1
A direct alkylation of resorcinols
Eleana Lopušanskaja, Anne Paju, Ivar Järving, et al.
Synthetic Communications (2023) Vol. 53, Iss. 15, pp. 1216-1226
Open Access | Times Cited: 1
Eleana Lopušanskaja, Anne Paju, Ivar Järving, et al.
Synthetic Communications (2023) Vol. 53, Iss. 15, pp. 1216-1226
Open Access | Times Cited: 1
Cannabidiol for the Treatment of Pediatric Epilepsy
J. Daniel
Pediatric Annals (2023) Vol. 52, Iss. 10
Closed Access | Times Cited: 1
J. Daniel
Pediatric Annals (2023) Vol. 52, Iss. 10
Closed Access | Times Cited: 1
Will Cannabis or Cannabinoids Protect You from SARS-CoV-2 Infection or Treat COVID-19?
Joshua D. Brown, Amie Goodin
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 32-35
Open Access | Times Cited: 1
Joshua D. Brown, Amie Goodin
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 32-35
Open Access | Times Cited: 1
